Advances in Ventricular and Inherited Arrhythmia Management

Lunch Symposium 3 : Contemporary Management in Ventricular Arrhythmias

Moderated by Alexander Edo Tondas, MD, PhD and Budi Ario Tejo, MD, Lunch Symposium 3 focused on contemporary approaches to ventricular arrhythmia management. Fera Hidayati, MD, in “State of the Art Ventricular Tachycardia - Latest Guideline Insights,” discussed the latest guideline-based approaches to ventricular tachycardia. Next, Aruman Yudanto, MD, in “The Role of ICD Therapy in Ventricular Tachycardia: From Primary Prevention to Advanced Therapy,” highlighted the evolving role of ICD therapy across different stages of VT management. The session concluded with Sunu Budhi Raharjo, MD, PhD, who presented “Digital Twins in EP: The Future of VT Ablation Planning,” exploring the potential of digital twin technology to advance personalized planning for VT ablation.  The session concluded with an interactive discussion and Q&A session. 

Symposium 15: Silent but Significant: Contemporary Management of Asymptomatic Inherited Arrhythmia Syndromes

Symposium 15 moderated by Chaerul Achmad, MD, PhD and Made Putra Swi Antara, MD, ocused on the challenges and emerging strategies in managing asymptomatic inherited arrhythmia syndromes. Budi Ario Tejo, MD, in “Red Flags for Inherited Arrhythmia Syndromes: A Practical Clinical Approach,” highlighted key clinical features that may help identify patients at risk and facilitate early recognition. Pipin Ardhianto, MD, in “Genetic Testing in Inherited Arrhythmia Syndromes: Who, When, and Why?”, emphasized a phenotype-first approach, testing with a clear purpose, and the importance of considering the family as the unit of care, to improve prevention for the entire family. Looking toward future therapies, Prof. Jong Il Choi, MD, PhD, in “Gene Editing and Gene Therapy in Arrhythmia Care: Where Do We Stand?”, discussed the current progress and potential of gene editing and gene therapy in inherited arrhythmia management.